ReviewThe oncologist2015

Oral Azacitidine (CC-486) for the Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemia.

Christopher R Cogle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.